Skip to content

Efficacy of Bharanghyadi Leha in Vataj Kasa

Randomized controlled clinical trail of Bharangyadi Leha in Vataj Kasa

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037318
Enrollment
60
Registered
2021-10-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J209- Acute bronchitis, unspecified

Interventions

Intervention1: Bharangyadi leha in vataj kasa.: Bharangyadi Leha 3gm TDS with gud and tail in vataj kasa for 7 days Control Intervention1: Dhurlabhadi Leha in vataj kasa.: Durlabhadi Leha 3 gram TDs w

Sponsors

Pratiksha Balaso Khandekar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having Lakshana of Vataj Kasa. Irrespective of gender and socioeconomic condition.

Exclusion criteria

Exclusion criteria: 1.Patients having history of Haemoptysis ,Hematemesis. 2.Patients having multisystem disease like DM-2, HTN, IHD, COPD, CKD or who are seriously ill. 3. Patients having Lung abcess ,pulmonary oedema, pleural effusion,ILD,CA. 4. Pregnancy and Lacting mother.

Design outcomes

Primary

MeasureTime frame
To determine the efficasy of Bharangyadi leha in vataj kasa.Timepoint: 4 weeks

Secondary

MeasureTime frame
To study the efficacy of Bharangyadi leha and Duralabhadi leha in vataj kasa.Timepoint: 18 months

Countries

India

Contacts

Public ContactPratiksha Balaso Khandekar

Hon Shri Annasaheb Dange Ayurvedic Medical College And Post Graduate Research Centre Ashta

pdeshmukhe@yahoo.co.in7719954457

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026